Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.44
+0.38 (1.89%)
Nov 24, 2025, 4:00 PM EST - Market closed
Neurogene Market Cap
Neurogene has a market cap or net worth of $316.61 million as of November 25, 2025. Its market cap has decreased by -66.59% in one year.
Market Cap
316.61M
Enterprise Value
61.41M
1-Year Change
-66.59%
Ranking
Category
Stock Price
$20.44
Market Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $316.61M, an increase of 63.51%. That is a compound annual growth rate of 29.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 310.73M | -8.50% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |